These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 34326317)
41. Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals. Deepika G; Adarsh S; Sadhana Y; Srihitha M; Veeraiah N; Reddy DN J Lab Physicians; 2023 Sep; 15(3):377-382. PubMed ID: 37564232 [No Abstract] [Full Text] [Related]
42. Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports. Basu S; Sharma H Cureus; 2023 Mar; 15(3):e36750. PubMed ID: 37123709 [TBL] [Abstract][Full Text] [Related]
43. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines. Al-Sheboul SA; Brown B; Shboul Y; Fricke I; Imarogbe C; Alzoubi KH Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679897 [TBL] [Abstract][Full Text] [Related]
44. HAT-field: a cheap, robust and quantitative Point-of-care serological test for Covid-19. Joly E; Maurel Ribes A Biol Methods Protoc; 2022; 7(1):bpac026. PubMed ID: 36457547 [TBL] [Abstract][Full Text] [Related]
46. Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers. Zare H; Rezapour H; Fereidouni A; Nikpour S; Mahmoudzadeh S; Royce SG; Fereidouni M Immun Ageing; 2022 Oct; 19(1):47. PubMed ID: 36273175 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection. Jeewandara C; Aberathna IS; Dayarathna S; Nimasha T; Ranasinghe T; Jayamali J; Kamaladasa A; Karunanada M; Perera L; Ogg GS; Malavige GN PLoS One; 2022; 17(10):e0274845. PubMed ID: 36227884 [TBL] [Abstract][Full Text] [Related]
48. Keeping up with the COVID's-Could siRNA-based antivirals be a part of the answer? Forgham H; Kakinen A; Qiao R; Davis TP Exploration (Beijing); 2022 Jul; 2(6):20220012. PubMed ID: 35941991 [TBL] [Abstract][Full Text] [Related]
49. Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka. Jeewandara C; Aberathna IS; Danasekara S; Gomes L; Fernando S; Guruge D; Ranasinghe T; Gunasekera B; Kamaladasa A; Kuruppu H; Somathilake G; Jayamali J; Jayathilaka D; Wijayatilake HDK; Pushpakumara PD; Harvie M; Nimasha T; de Silva SDG; Wijayamuni R; Schimanski L; Rijal P; Tan J; Townsend A; Ogg GS; Malavige GN Immunology; 2022 Oct; 167(2):263-274. PubMed ID: 35751563 [TBL] [Abstract][Full Text] [Related]
50. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India. Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093 [TBL] [Abstract][Full Text] [Related]
51. Impact of ChAdOx1 nCoV-19 (Covishield™) Vaccination: How Long Will It Persist? Devi LS; Sardar M; Sharma M; Khandait M Int J Microbiol; 2022; 2022():4729844. PubMed ID: 35685779 [TBL] [Abstract][Full Text] [Related]
52. Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222. Jayathilaka D; Jeewandara C; Gomes L; Jayadas TTP; Kamaladasa A; Somathilake G; Guruge D; Pushpakumara PD; Ranasinghe T; Aberathna IS; Danasekara S; Gunathilaka B; Kuruppu H; Wijewickrama A; Wijayamuni R; Schimanski L; Tan TK; Ogg GS; Townsend A; Malavige GN Clin Exp Immunol; 2022 Jun; 208(3):323-331. PubMed ID: 35641142 [TBL] [Abstract][Full Text] [Related]
54. A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. Ertesvåg NU; Xiao J; Zhou F; Ljostveit S; Sandnes H; Lartey S; Sævik M; Hansen L; Madsen A; Mohn KGI; Fjelltveit E; Olofsson JS; Tan TK; Rijal P; Schimanski L; Øyen S; Brokstad KA; Dunachie S; Jämsén A; James WS; Harding AC; Harvala H; Nguyen D; Roberts D; ; Zambon M; ; Townsend A; ; Langeland N; Cox RJ Commun Med (Lond); 2022; 2():36. PubMed ID: 35603265 [TBL] [Abstract][Full Text] [Related]
55. Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies. Guo D; Duan H; Cheng Y; Wang Y; Hu J; Shi H Mol Biomed; 2022 Apr; 3(1):12. PubMed ID: 35461370 [TBL] [Abstract][Full Text] [Related]
56. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis. Tung KT; Peng YS; Hsu SP; Wu HY; Chiu YL; Yang JY; Pai MF; Shu KH; Pan SY; Lu HM; Lin WY; Liao CH; Chu FY; Tsai WC Hemodial Int; 2022 Jul; 26(3):369-376. PubMed ID: 35411681 [TBL] [Abstract][Full Text] [Related]
57. Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals. Jeewandara C; Aberathna IS; Gomes L; Pushpakumara PD; Danasekara S; Guruge D; Ranasinghe T; Gunasekera B; Kamaladasa A; Kuruppu H; Somathilake G; Dissanayake O; Gamalath N; Ekanayake D; Jayamali J; Jayathilaka D; Mudunkotuwa A; Harvie M; Nimasha T; Wijayamuni R; Schimanski L; Rijal P; Tan TK; Dong T; Townsend A; Ogg GS; Malavige GN Immun Inflamm Dis; 2022 Apr; 10(4):e592. PubMed ID: 35349749 [TBL] [Abstract][Full Text] [Related]
58. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. Brumme ZL; Mwimanzi F; Lapointe HR; Cheung PK; Sang Y; Duncan MC; Yaseen F; Agafitei O; Ennis S; Ng K; Basra S; Lim LY; Kalikawe R; Speckmaier S; Moran-Garcia N; Young L; Ali H; Ganase B; Umviligihozo G; Omondi FH; Atkinson K; Sudderuddin H; Toy J; Sereda P; Burns L; Costiniuk CT; Cooper C; Anis AH; Leung V; Holmes D; DeMarco ML; Simons J; Hedgcock M; Romney MG; Barrios R; Guillemi S; Brumme CJ; Pantophlet R; Montaner JSG; Niikura M; Harris M; Hull M; Brockman MA NPJ Vaccines; 2022 Feb; 7(1):28. PubMed ID: 35228535 [TBL] [Abstract][Full Text] [Related]
59. Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals. Hwang JY; Kim Y; Lee KM; Jang EJ; Woo CH; Hong CU; Choi ST; Xayaheuang S; Jang JG; Ahn JH; Park H Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214791 [TBL] [Abstract][Full Text] [Related]
60. The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study. Perkmann T; Mucher P; Perkmann-Nagele N; Radakovics A; Repl M; Koller T; Schmetterer KG; Bigenzahn JW; Leitner F; Jordakieva G; Wagner OF; Binder CJ; Haslacher H Microbiol Spectr; 2022 Feb; 10(1):e0140221. PubMed ID: 35196824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]